These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 18487993)

  • 1. ZEB1 expression in type I vs type II endometrial cancers: a marker of aggressive disease.
    Singh M; Spoelstra NS; Jean A; Howe E; Torkko KC; Clark HR; Darling DS; Shroyer KR; Horwitz KB; Broaddus RR; Richer JK
    Mod Pathol; 2008 Jul; 21(7):912-23. PubMed ID: 18487993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The transcription factor ZEB1 is aberrantly expressed in aggressive uterine cancers.
    Spoelstra NS; Manning NG; Higashi Y; Darling D; Singh M; Shroyer KR; Broaddus RR; Horwitz KB; Richer JK
    Cancer Res; 2006 Apr; 66(7):3893-902. PubMed ID: 16585218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ZEB1 overexpression associated with E-cadherin and microRNA-200 downregulation is characteristic of undifferentiated endometrial carcinoma.
    Romero-Pérez L; López-García MÁ; Díaz-Martín J; Biscuola M; Castilla MÁ; Tafe LJ; Garg K; Oliva E; Matias-Guiu X; Soslow RA; Palacios J
    Mod Pathol; 2013 Nov; 26(11):1514-24. PubMed ID: 23743934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laminin C1 expression by uterine carcinoma cells is associated with tumor progression.
    Kashima H; Wu RC; Wang Y; Sinno AK; Miyamoto T; Shiozawa T; Wang TL; Fader AN; Shih IeM
    Gynecol Oncol; 2015 Nov; 139(2):338-44. PubMed ID: 26343160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ZEB1 expression in endometrial biopsy predicts lymph node metastases in patient with endometrial cancer.
    Feng G; Wang X; Cao X; Shen L; Zhu J
    Dis Markers; 2014; 2014():680361. PubMed ID: 25544793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epithelial to mesenchymal transition in early stage endometrioid endometrial carcinoma.
    Montserrat N; Mozos A; Llobet D; Dolcet X; Pons C; de Herreros AG; Matias-Guiu X; Prat J
    Hum Pathol; 2012 May; 43(5):632-43. PubMed ID: 21940036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stromal Clues in Endometrial Carcinoma: Loss of Expression of β-Catenin, Epithelial-Mesenchymal Transition Regulators, and Estrogen-Progesterone Receptor.
    Senol S; Sayar I; Ceyran AB; Ibiloglu I; Akalin I; Firat U; Kosemetin D; Engin Zerk P; Aydin A
    Int J Gynecol Pathol; 2016 May; 35(3):238-48. PubMed ID: 26367784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Could E-Cadherin and CD10 Expression be Used to Differentiate Between Atypical Endometrial Hyperplasia and Endometrial Carcinoma?
    Youssef MY; Mohamed MA
    Int J Gynecol Pathol; 2019 Mar; 38(2):128-137. PubMed ID: 30726192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The oncofetal protein IMP3: a novel biomarker for endometrial serous carcinoma.
    Zheng W; Yi X; Fadare O; Liang SX; Martel M; Schwartz PE; Jiang Z
    Am J Surg Pathol; 2008 Feb; 32(2):304-15. PubMed ID: 18223334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of epithelial-mesenchymal transition factors in the histogenesis of uterine carcinomas.
    Franceschi T; Durieux E; Morel AP; de Saint Hilaire P; Ray-Coquard I; Puisieux A; Devouassoux-Shisheboran M
    Virchows Arch; 2019 Jul; 475(1):85-94. PubMed ID: 30739164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-catenin and E-cadherin expression patterns in high-grade endometrial carcinoma are associated with histological subtype.
    Schlosshauer PW; Ellenson LH; Soslow RA
    Mod Pathol; 2002 Oct; 15(10):1032-7. PubMed ID: 12379748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunolocalization of ERK1/2 and p-AKT in normal endometrium, endometrial hyperplasia, and early and advanced stage endometrioid endometrial adenocancer and their prognostic significance in malignant group.
    Gungorduk K; Ertas IE; Sahbaz A; Ozvural S; Sarica Y; Ozdemir A; Sayhan S; Gokcu M; Yilmaz B; Sanci M; Inan S; Harma M; Yildirim Y
    Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():147-52. PubMed ID: 24965996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of epithelial mesenchymal transition markers in thyroid carcinoma progression.
    Montemayor-Garcia C; Hardin H; Guo Z; Larrain C; Buehler D; Asioli S; Chen H; Lloyd RV
    Endocr Pathol; 2013 Dec; 24(4):206-12. PubMed ID: 24126800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factor-I-dependent up-regulation of ZEB1 drives epithelial-to-mesenchymal transition in human prostate cancer cells.
    Graham TR; Zhau HE; Odero-Marah VA; Osunkoya AO; Kimbro KS; Tighiouart M; Liu T; Simons JW; O'Regan RM
    Cancer Res; 2008 Apr; 68(7):2479-88. PubMed ID: 18381457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of nm23 in normal, hyperplastic and neoplastic endometrial tissues.
    Brustmann H; Naudé S
    Pathol Res Pract; 1999; 195(12):829-34. PubMed ID: 10631718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical analysis of the expression of E-cadherin and ZEB1 in non-small cell lung cancer.
    Matsubara D; Kishaba Y; Yoshimoto T; Sakuma Y; Sakatani T; Tamura T; Endo S; Sugiyama Y; Murakami Y; Niki T
    Pathol Int; 2014 Nov; 64(11):560-8. PubMed ID: 25347933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PINCH protein expression in normal endometrium, atypical endometrial hyperplasia and endometrioid endometrial carcinoma.
    Zhang HZ; Li XH; Zhang X; Zhang ZY; Meng YL; Xu SW; Zheng Y; Zhu ZL; Cui DS; Huang LX; Yan BY; Sun XF
    Chemotherapy; 2010; 56(4):291-7. PubMed ID: 20714146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of WWOX tumor suppressor gene in the regulation of EMT process via regulation of CDH1-ZEB1-VIM expression in endometrial cancer.
    Płuciennik E; Nowakowska M; Pospiech K; Stępień A; Wołkowicz M; Gałdyszyńska M; Popęda M; Wójcik-Krowiranda K; Bieńkiewicz A; Bednarek AK
    Int J Oncol; 2015; 46(6):2639-48. PubMed ID: 25892250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the ZEB1 (deltaEF1) transcription factor in human: additional insights.
    Hurt EM; Saykally JN; Anose BM; Kalli KR; Sanders MM
    Mol Cell Biochem; 2008 Nov; 318(1-2):89-99. PubMed ID: 18622689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological significance of ZEB1 protein in patients with hepatocellular carcinoma.
    Zhou YM; Cao L; Li B; Zhang RX; Sui CJ; Yin ZF; Yang JM
    Ann Surg Oncol; 2012 May; 19(5):1700-6. PubMed ID: 21584833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.